XTANT MEDICAL HOLDINGS, INC. (XTNT) Gross margin 2016–2025
XTANT MEDICAL HOLDINGS, INC. (XTNT) gross margin by fiscal year — reported gross profit divided by reported revenue.
62.9%FY2025 · since FY2016: 69.2% → 62.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 62.9% | +4.8 pp |
| FY2024 | 58.2% | -2.6 pp |
| FY2023 | 60.8% | +5.3 pp |
| FY2022 | 55.4% | -3.4 pp |
| FY2021 | 58.8% | -5.7 pp |
| FY2020 | 64.5% | -1.3 pp |
| FY2019 | 65.7% | +5.5 pp |
| FY2018 | 60.2% | -0.4 pp |
| FY2017 | 60.6% | -8.6 pp |
| FY2016 | 69.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More XTNT financial trends
XTNT RevenueXTNT Net incomeXTNT Net marginXTNT Gross profitXTNT Operating incomeXTNT Operating marginXTNT Operating cash flowXTNT Free cash flowXTNT Capital expendituresXTNT Return on equityXTNT Stock buybacksXTNT Dividends paidXTNT Total assetsXTNT Total liabilitiesXTNT Shareholders’ equityXTNT overview →